RISEDRONATE DECREASES FRACTURES AND COSTS OF POSTMENOPAUSAL OSTEOPOROSIS IN GERMANY

被引：0
|
作者：
Moehrke, W. [1 ]
Abendroth, K. [2 ]
Kruse, H. [3 ]
机构：
[1] Warner Chilcott Deutschland GmbH, Dept Med, Weiterstadt, Germany
[2] Warner Chilcott Deutschland GmbH, Jena, Germany
[3] Warner Chilcott Deutschland GmbH, Osteoporosezentrum, Hamburg, Germany
来源：
OSTEOPOROSIS INTERNATIONAL | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：250 / 250
页数：1
相关论文
共 50 条
  • [1] Risedronate for the prevention of fractures in postmenopausal osteoporosis
    Sickels, JM
    Nip, CS
    [J]. ANNALS OF PHARMACOTHERAPY, 2002, 36 (04) : 664 - 670
  • [2] Risedronate reduces vertebral fractures in postmenopausal women with osteoporosis
    Jackson, R
    Bensen, W
    Ettinger, M
    Eastell, R
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (08) : S85 - S85
  • [3] Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures
    Ohtori, Seiji
    Akazawa, Tsutomu
    Murata, Yasuaki
    Kinoshita, Tomoaki
    Yamashita, Masaomi
    Nakagawa, Koichi
    Inoue, Gen
    Nakamura, Junichi
    Orita, Sumihisa
    Ochiai, Nobuyasu
    Kishida, Shunji
    Takaso, Masashi
    Eguchi, Yawara
    Yamauchi, Kazuyo
    Suzuki, Munetaka
    Aoki, Yasuchika
    Takahashi, Kazuhisa
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2010, 17 (02) : 209 - 213
  • [4] Risedronate Rapidly Reduces the Risk for Nonvertebral Fractures in Women with Postmenopausal Osteoporosis
    J. T. Harrington
    L. -G. Ste-Marie
    M. L. Brandi
    R. Civitelli
    P. Fardellone
    A. Grauer
    I. Barton
    S. Boonen
    [J]. Calcified Tissue International, 2004, 74 : 129 - 135
  • [5] Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis
    Harrington, JT
    Ste-Marie, LG
    Brandi, ML
    Civitelli, R
    Fardellone, P
    Grauer, A
    Barton, I
    Boonen, S
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2004, 74 (02) : 129 - 135
  • [6] Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
    J. A. Kanis
    F. Borgstrom
    O. Johnell
    B. Jonsson
    [J]. Osteoporosis International, 2004, 15 : 862 - 871
  • [7] Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
    Kanis, JA
    Borgstrom, F
    Johnell, O
    Jonsson, B
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 (11) : 862 - 871
  • [8] Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis
    J.-Y. Reginster
    H. W. Minne
    O. H. Sorensen
    M. Hooper
    C. Roux
    M. L. Brandi
    B. Lund
    D. Ethgen
    S. Pack
    I. Roumagnac
    R. Eastell
    [J]. Osteoporosis International, 2000, 11 : 83 - 91
  • [9] Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
    Reginster, JY
    Minne, HW
    Sorensen, OH
    Hooper, M
    Roux, C
    Brandi, ML
    Lund, B
    Ethgen, D
    Pack, S
    Roumagnac, I
    Eastell, R
    [J]. OSTEOPOROSIS INTERNATIONAL, 2000, 11 (01) : 83 - 91
  • [10] Monthly risedronate (Actonel) for postmenopausal osteoporosis
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2008, 50 (1294): : 69 - 70
12345